You are here

Other Cohort Studies


RV230 was MHRP's initial effort to assess potential field sites for HIV vaccine studies in Nigeria. The study began in 2009 and enrolled 550 participants; it assessed HIV-1, HIV-2, and hepatitis B and C prevalence along with the molecular diversity of HIV-1 within these populations. The study identified at least two communities in Nigeria with the potential to meet criteria for vaccine development research, with volunteers reporting a high level of willingness to participate in future HIV intervention studies


In 2013, MHRP initiated a cohort study (RV363) to determine incidence in men and women aged 18-35 in Maputo in collaboration with National Institute of Health (CISPOC).

Western Kenya

This study, in Kombewa Kenya is titled: “Cohort and Development to Assess Incidence of HIV Infection, Retention Rate and Willingness of adults to participate in future HIV Vaccine trials in Western Kenya.” The study began in 2014.